http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BG-66437-B1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f2d3599fb8f8f479dba95ca9bb504884 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5377 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-506 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-496 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-497 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4704 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4709 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-47 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-47 |
| filingDate | 2005-06-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7748f2330cf87bf4e7019fa3293400bc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_197118308f6077fa5842cc84f13aaf08 |
| publicationDate | 2014-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | BG-66437-B1 |
| titleOfInvention | USE OF QUINOLINE COMPOUNDS FOR TREATMENT OF LATENT TUBERCULOSIS |
| abstract | Use of a compound of formula (Ia) and (Ib) for the manufacture of a medicament for treating latent tuberculosis wherein the compound of formula (Ia) or (Ib) is a pharmaceutically acceptable acid addition or base addition salt, N-oxide, a tautomeric or stereochemically isomeric form thereof, wherein R1 is hydrogen, halogen, haloalkyl, cyano, hydroxy, Ar, Het, alkyl, alkyloxy, alkylthio, alkyloxyalkyl, alkylthioalkyl, Ar-alkyl or di (Ar) alkyl; p 1, 2, 3 or 4; R2 is hydrogen, hydroxy, mercapto, alkyloxy, alkyloxyalkyloxy, alkylthio, mono or di (alkyl) amino or a radical of the formula R3 is alkyl, Ar-alkyl, Het or Het-alkyl; q is zero, 1, 2, 3 or 4; each R4 and R5 is independently hydrogen, alkyl or benzyl; or R 4 and R 5 may be taken together with the nitrogen to which they are attached; R6 is hydrogen, halogen, haloalkyl, hydroxy, Ar, alkyl, alkyloxy, alkylthio, alkyloxyalkyl, alkylthioalkyl, Ar-alkyl or di (Ar) alkyl; or two adjacent R6 radicals may be taken together to form a divalent radical; -CH = CH-CH = CH-; r is 1, 2, 3, 4 or 5; R7 is hydrogen, alkyl, Ar or Het; R8 is hydrogen or alkyl; R9 is oxo; R8 and R9 together form a radical = N-CH = CH- |
| priorityDate | 2004-12-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 236.